October 2026
Includes: AI-Powered Pathology Biomarker Predicts Survival, First commercial procedures performed with Zenflow Spring for BPH, Cancer’s ‘rogue DNA’,
Understanding Your Treatment Options: Questions to Ask After a Prostate Cancer Diagnosis
Once the initial shock of a prostate cancer diagnosis starts to settle, the next challenge often begins: making sense of […]
Newly Diagnosed with Prostate Cancer: What to Expect in the First Few Weeks
Hearing the words “you have prostate cancer” can stop you in your tracks. Even if you suspected something was wrong, […]
September 2026
Includes: New drug combination may help treat advanced prostate cancer, Half of prostate cancer focal therapy use falls outside guideline-supported groups,
August 2026
Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,
New Frontiers: Research Advances for High-Risk and Advanced Prostate Cancer
Beyond imaging and genetic testing, several distinct lines of research reported in 2026 are reshaping how doctors think about high-risk […]
The Genetic Turn: PARP Inhibitors Move Earlier in Prostate Cancer Treatment
One of the most consequential developments in prostate cancer research this year has nothing to do with a new drug […]
Seeing and Striking the Target: How PSMA Is Transforming Prostate Cancer Care
Prostate cancer research in 2026 has been defined by a single molecule: PSMA, or prostate-specific membrane antigen. This protein sits […]
July 2026
Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,
PARP Inhibitors: Recent Research Advancements in Prostate Cancer (2025–2026)
PARP inhibitors are among the most significant advances in precision medicine for prostate cancer. These drugs work by blocking DNA […]